-transparent.png){kind=logo}
Prolonged effect (6-12 months) of verapamil and nifedipine on the systolic and diastolic function of the myocardium was studied in 48 patients with hypertensive disease (stage II). It was established that in patients with a high ejection fraction (55% and more) the two drugs produce a distinct reduction of the pumping heart function. The two drugs increase the rate of early diastolic filling. They also may reduce the arterial pressure via different hemodynamic mechanisms: vasodilatation or via reduction of cardiac output.
Related Publications
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 2002,
Kardiologiia,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 1992,
Terapevticheskii arkhiv,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 1992,
Terapevticheskii arkhiv,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 1983,
Hypertension (Dallas, Tex. : 1979),
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
September 1980,
British heart journal,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
December 1985,
The American journal of cardiology,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
August 1996,
Blood pressure monitoring,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 1988,
Journal of cardiovascular pharmacology,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 1985,
International journal of clinical pharmacology research,
E P Svishchenko, and
O I Korchinskaia, and
N P Stroganova, and
V V Radchenko
January 2008,
Terapevticheskii arkhiv,
